Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA New Drug Review Performance May Miss Lowered Expectations – Jenkins

Related Content

CDER New Drug Reviews Are At 80%-90% Of User Fee Goals, Jenkins Says

Aug 18 2008

FDA Misses User Fee Goals As Resources Tighten For Application Reviews, SPAs

Mar 17 2008

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window